Q61967719 | A Continuous, Non-Invasive, Real-time Method for Estimating and Predicting Intracranial Hypertension |
Q66075669 | A Stepped Care Intervention to Reduce Disparities in Mental Health Services Among Cancer Patients and Caregivers |
Q64139668 | A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication |
Q63571069 | A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock. |
Q61924871 | A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) |
Q66037503 | A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects |
Q63403966 | Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel |
Q65536342 | Accuracy of the Transpatellar Tendon Approach to Knee Arthrocentesis |
Q63834502 | An Intervention to Improve Communication Between Physicians and Minority Patients With Hypertension |
Q98604686 | An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients |
Q61917729 | Anticoagulation in Blunt Cerebrovascular Injuries |
Q66042332 | Apoyo Con Carino: Patient Navigation for Palliative Care for Non-Cancer Illness |
Q64122933 | Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy |
Q66041329 | Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery |
Q62812440 | Assisting in Decisions in Emergency Departments: (ED-AID) Study |
Q65353785 | At-risk Intervention and Mentoring Evaluation |
Q65385868 | Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder |
Q64693973 | Automated Diabetes Registry Tools to Enhance Patient Self-Management and Provider Performance Feedback |
Q63570976 | Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome |
Q65544150 | BRAIN (Biomarker Rapid Assessment of Ischemic iNjury) |
Q65379895 | BacLite Rapid MRSA Clinical Performance |
Q64652448 | Bacterial Contamination of Workwear |
Q65472772 | Beta Blockade in Critical Injury |
Q65365764 | Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma |
Q64123051 | Breast Cancer WEight Loss Study (BWEL Study) |
Q64151920 | Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma |
Q66042562 | Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer |
Q64172251 | Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia |
Q63401371 | Cancer Health Assessments Reaching Many |
Q65541080 | Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer |
Q64171079 | Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery |
Q63590566 | Chronic Hypertension and Pregnancy (CHAP) Project |
Q63807890 | Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases |
Q58846742 | Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer |
Q65372308 | Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury |
Q64636220 | Collaborative Care to Alleviate Symptoms and Adjust to Illness in Chronic Heart Failure (CASA) Trial |
Q58845885 | Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair |
Q58845987 | Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer |
Q64121135 | Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery |
Q64349985 | Community Outreach - Obesity Prevention Trial (CO-OPT) |
Q65384809 | Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease |
Q64123525 | Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy |
Q64598381 | Comparison of Epidural and Paracostal Catheter Placement for Pain Control After Rib Fractures |
Q63320331 | Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma |
Q66042124 | Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis |
Q64349490 | Compassionate Use of Ibalizumab for the Treatment of HIV Infection |
Q107214111 | Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder |
Q66343527 | Control of Major Bleeding After Trauma Study |
Q63807956 | Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) |
Q64803138 | Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis |
Q61864729 | Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery |
Q64396266 | Diabetes Group Prenatal Care |
Q61908856 | Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence |
Q65345980 | Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer |
Q65383627 | Drug Study of Albuterol to Treat Acute Lung Injury |
Q64395693 | Dual Protection Project |
Q61969726 | Duration of Antibiotic Treatment for Early VAP (DATE) Trial |
Q64805936 | Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer |
Q64724598 | Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study) |
Q64679306 | Early Versus Delayed Enteral Feeding to Treat People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN Study) |
Q65388061 | Effects of Carvedilol on Health Outcomes in Heart Failure |
Q63831827 | Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury |
Q64661887 | Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures |
Q66034546 | Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma |
Q63590682 | Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) |
Q64675402 | Eslicarbazepine Acetate Monotherapy Long Term Study |
Q66034523 | Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) |
Q66039529 | Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. |
Q61906994 | Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502 |
Q63062423 | Evaluation of Opt-Out Rapid HIV Testing in the Emergency Department |
Q64724182 | Examining Heart Attacks in Young Women |
Q64650096 | Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management |
Q61904920 | Exploration of Pupil Dilation in Horner's Patients Taking Flomax |
Q64837669 | Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD |
Q66083748 | FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer |
Q62817334 | Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment |
Q63572880 | Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer |
Q64353837 | Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery |
Q63321327 | GLORIA-AF Registry Program - Second and Third Phases |
Q64603532 | Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population |
Q63590679 | Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) |
Q66076564 | Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma |
Q61978953 | Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection |
Q63405187 | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer |
Q63590425 | Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma |
Q63587725 | Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia |
Q64150388 | Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia |
Q64337001 | Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
Q66068917 | Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders |
Q65382590 | Improving Blood Pressure in Colorado |
Q66033573 | Improving Prevention of Heart Disease in Latinos |
Q64173108 | Increasing Infant Preventive Health Service Delivery in an Inner City Population |
Q64693195 | Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) |
Q61933964 | Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema |
Q63813137 | Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery |
Q64601666 | IrrSept vs. Standard of Care in Prevention of Surgical Site Infections |
Q63808084 | Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma |
Q63832074 | Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma |
Q65387862 | Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer |
Q66079124 | Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer |
Q58407878 | Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers |
Q64806376 | Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer |
Q64151321 | Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches |
Q64350946 | Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses |
Q66075397 | Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer |
Q65383321 | Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET) |
Q66069411 | Multicenter RCT of SSRF in Non Flail Patients |
Q64122810 | Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer |
Q63570896 | Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer |
Q64151640 | Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery |
Q58845348 | Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
Q58407779 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
Q64699098 | NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures |
Q64658484 | Novel Influenza A (H1N1) Surveillance Registry |
Q63572769 | Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma |
Q63573996 | Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy |
Q63571541 | Olaparib and Cediranib Maleate in Treating Patients With Recurrent, Refractory, or Metastatic Endometrial Cancer |
Q65390538 | Open-label Study With Bosentan in Interstitial Lung Disease |
Q65355930 | Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location |
Q63808123 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer |
Q64645908 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery |
Q58845627 | Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
Q61915165 | Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE) |
Q61921169 | Pilot Study of Haloperidol to Treat Critical Illness Delirium |
Q64396112 | Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy |
Q66061140 | Presessions for the National Diabetes Prevention Program |
Q65359128 | Procedure For The Reference Range Study For Absolute MA |
Q63592318 | Pupil Dilation for Treatment of IFIS |
Q64348399 | RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone |
Q64716042 | Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy |
Q64351191 | Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically Ill |
Q65339213 | Reevaluation Of Systemic Early Neuromuscular Blockade |
Q64835736 | Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission |
Q63807988 | Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia |
Q62025050 | Ruxolitinib Phosphate and Dasatinib or Nilotinib in Treating Patients With Chronic Myeloid Leukemia |
Q66034572 | S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer |
Q66035610 | S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer |
Q66031482 | S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer |
Q66029847 | S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy |
Q62105632 | S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer |
Q65541090 | S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer |
Q64714915 | S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo |
Q64665344 | S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer |
Q65371643 | S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer |
Q64611002 | S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer |
Q65355356 | S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer |
Q63578083 | S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer |
Q64807050 | S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery |
Q63399475 | S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis |
Q66038067 | S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma |
Q64070727 | SILVER-AMI: Outcomes in Older Persons With Heart Attacks |
Q65537312 | Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization |
Q65378392 | Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis |
Q61980958 | Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs |
Q66035427 | Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting |
Q63815430 | Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis |
Q63597894 | Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer |
Q66067639 | Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia |
Q63012447 | Splenic Injury Embolization - the Question About NOM (SInE Qua NOM) |
Q65536328 | Splinting Versus Not Splinting of the Distal Lower Extremity After Intramedullary Nailing for Tibial Fractures |
Q64698853 | Statins for Acutely Injured Lungs From Sepsis |
Q63316379 | Stress Echo Ultrasound Contrast in an Urban Safety Net Hospital to Refine Ischemia Evaluation |
Q64335584 | Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections |
Q64719527 | Study of New Catheter & Pressure Monitor System to Help Prevent Compartment Syndrome From Developing in the Injured Leg |
Q63599826 | Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza |
Q63816718 | Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections |
Q64673076 | Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill Patients |
Q61936945 | Study to Determine if the Valiant Stent Graft is Safe and Effective in Treating Patients Who Have a Blunt Thoracic Aortic Injury |
Q63399234 | Study to Evaluate the Efficacy and Safety of APL-2 in Patients With PNH |
Q65391372 | Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery |
Q66035229 | Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer |
Q65384412 | Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer |
Q63590421 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) |
Q64718286 | Telephone Support Intervention to Improve Breastfeeding |
Q64223280 | Text Messaging for Weight Loss |
Q61975490 | The AVERT Sepsis Investigation |
Q64657464 | The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma |
Q66060386 | The DETECT HCV Linkage to Care Trial |
Q66064076 | The DETECT HCV Screening Trial |
Q66067248 | The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy |
Q62040321 | The Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural Connectivity |
Q63572887 | The Respiratory Protection Effectiveness Clinical Trial |
Q65340360 | The Role of VAC Therapy Devices in Promoting Closure of Enterocutaneous Fistulae |
Q64666340 | Tibial Delayed Healing Pivotal Clinical Trial |
Q61969449 | Ticagrelor in Severe Community Acquired Pneumonia |
Q64188894 | Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer |
Q64219820 | Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer |
Q64794898 | Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication |
Q63811458 | Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures |
Q65343785 | Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood |
Q65362511 | Urinary Heparanase Activity as a Predictor of Acute Kidney Injury in Critically Ill Adults |
Q62821482 | Vitamin C, Thiamine, and Steroids in Sepsis |
Q66046664 | Vitamin D to Improve Outcomes by Leveraging Early Treatment |
Q66038125 | Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial |
Q61917750 | Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study) |
Q63813763 | Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study |